drugset

drugset / Trial / NCT00414856

Effects of AFQ056 and Baclofen on Meal-Induced Gastroesophageal Reflux

NCT00414856 ↗

Phase 1 Completed 34 enrolled Novartis

RandomizedCrossoverDouble-blindTreatment

Summary

This study will assess the safety and tolerability of oral single dose applications of AFQ056 in GERD patients.

Timeline

Start: 2006-08
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Mavoglurant	Small molecule	—	Oral

Indications